Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Researchers at Lilly disclose novel kinase inhibitors

Aug. 8, 2012

New anticancer microRNA prepared in the Netherlands

Aug. 8, 2012

Crystal Biopharmaceutical patents novel camptothecin derivatives

Aug. 8, 2012

ACEA Biosciences presents new candidate cancer therapeutics

Aug. 8, 2012

Phase III trial in NSCLC does not meet primary endpoint

Aug. 7, 2012

PharmaEngine and Nanobiotix enter license and collaboration agreement for radioenhancer

Aug. 7, 2012

Phase II Zybrestat combination study meets safety criteria

Aug. 7, 2012

Rexahn completes exploratory RX-3117 study

Aug. 7, 2012

Research at Bioenergenix yields novel PAS-kinase inhibitors

Aug. 7, 2012

Novel protein kinase inhibitors disclosed

Aug. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.